# Implications of mtDNA in human health and diseases

**Authors:** Smruthi Seethashankar, Shruti Hariharan, Venkatachalam Deepa Parvathi

PMC · DOI: 10.5114/bta/204532 · BioTechnologia · 2025-06-30

## TL;DR

Mitochondrial DNA (mtDNA) mutations and copy number changes are linked to various diseases, highlighting their role in human health and potential for diagnosis and treatment.

## Contribution

This paper reviews the implications of mtDNA variations and mutations in multiple diseases, emphasizing their diagnostic and therapeutic relevance.

## Key findings

- mtDNA copy number variations are associated with cancers, neurodegenerative, cardiovascular, and kidney disorders.
- Mutations in mitochondrial DNA can affect multiple organs and contribute to diseases like cardiomyopathy and Parkinson’s.
- mtDNA mutations and copy number changes may serve as diagnostic and prognostic markers for mitochondrial-related diseases.

## Abstract

The maternally inherited autonomous organelles, mitochondria, are responsible for a myriad of functions within the cell. They may contain more than one copy of DNA and can themselves be present in multiple numbers within a cell. The integrity of the mitochondrial genome is affected by variations in DNA copy number or the presence of mutations. Compromising this integrity has been documented to result in disorders affecting various systems. Focusing on such trends could enhance knowledge essential for developing strategies to manage these disorders. Irregular patterns of mitochondrial DNA (mtDNA) copy number (CN) variation have been identified in various cancers. Reduced mtDNA CN has been associated with neurodegenerative disorders, cardiovascular diseases, and kidney disorders. Mutations in the mitochondrial respiratory chain complex have been linked to cardiomyopathy. High rates of mtDNA deletions have been found in aging patients and subjects with Parkinson’s disease. While sperm function appears to deteriorate with increased mtDNA CN, oogenesis involves a significant increase to enable the oocyte to achieve fertilization and further development. Prospective therapies to treat mitochondrial diseases may include approaches that aim to reduce the levels of mutant mtDNA below the disease-causing threshold, such as targeted removal of defective mitochondria. Mutations in mitochondrial DNA contribute to various diseases; some single substitutions appear to disrupt the normalcy of more than one organ, underscoring the importance of mitochondrial genome integrity. The presence of mutations and copy number variations may serve as diagnostic markers and also provide insight into prognosis.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), cardiomyopathy (MONDO:0004994), Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** Parkinson's disease (MESH:D010300), kidney disorders (MESH:D007674), neurodegenerative disorders (MESH:D019636), mitochondrial diseases (MESH:D028361), cardiovascular diseases (MESH:D002318), cardiomyopathy (MESH:D009202), cancers (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12281495/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12281495/full.md

## References

98 references — full list in the complete paper: https://tomesphere.com/paper/PMC12281495/full.md

---
Source: https://tomesphere.com/paper/PMC12281495